<?xml version="1.0" encoding="utf-8" standalone="yes"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom"><channel><title>Biotech on SAUDI VISION 2030 Intelligence Platform</title><link>https://vision2030.ai/tags/biotech/</link><description>Recent content in Biotech on SAUDI VISION 2030 Intelligence Platform</description><generator>Hugo</generator><language>en</language><lastBuildDate>Sat, 18 Apr 2026 00:00:00 +0000</lastBuildDate><atom:link href="https://vision2030.ai/tags/biotech/feed.xml" rel="self" type="application/rss+xml"/><item><title>Biotech and Life Sciences Investment</title><link>https://vision2030.ai/investment/guides/biotech-investment/</link><pubDate>Sun, 22 Feb 2026 00:00:00 +0000</pubDate><guid>https://vision2030.ai/investment/guides/biotech-investment/</guid><description>&lt;h2 id="biotech-and-life-sciences-investment-in-saudi-arabia">Biotech and Life Sciences Investment in Saudi Arabia&lt;/h2>
&lt;p>Saudi Arabia&amp;rsquo;s biotech and life sciences investment opportunity spans pharmaceutical manufacturing, clinical research and CRO services, genomics, medical devices, and SFDA-regulated routes to market.&lt;/p>
&lt;p>The sector is emerging from a nascent stage into a strategically important investment category, driven by the Kingdom&amp;rsquo;s &lt;a href="https://vision2030.ai/investment/healthcare/">healthcare&lt;/a> spending of over SAR 200 billion annually, a pharmaceutical market valued at approximately SAR 40 to 45 billion, and government commitment to developing domestic life sciences capabilities that reduce import dependency and create high-value employment opportunities.&lt;/p></description></item></channel></rss>